---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "8M5HIcko3fNZaY6YLeNwMG7jTHVyoeyBAmmhxnTgoBusXmRHXf+YfPoSI3OGn9UBcyzIRIl9YoDngF0StnTNJ4Eq7qeZrKlJGmCoKgzDI41lumjqZSPOq9fWN1/S8s7QKI47YhRM3pBSQwarVEMSQ2dBTQ5NQtsi32HK0D5t2EZdX6tHrRcf0RS8qq8JZFI+NBFCUthVhCDydQyNtWjVzYeIPzQtaTmktZ5qTqgJT39X0hb/+5K+E3oqT7fBFd4wjXAunsyGV2mhc5xDS1P0xYCaTQ1sk+jSB2sF+1ZP+hhA7+ybyPsw7VkGRdPmtm/U;0cZFHWcJjJrwRcesEsbjTQ=="
---

